Press release from Companies
Published: 2022-09-12 15:24:57
EQL has been named the best logistics provider of the year in the area self-care by Apotek Hjärtat. The motivation was "During the last year EQL has shown strength, huge will, entrepreneurship and flexibility. We are immensely grateful for the extra nice cooperation that we have had during the year where EQL has secured high quality deliveries of this year´s highest runner, COVID tests".
"During 2021 and 2022 our team has worked hard to supply COVID tests to Apotek Hjärtat. This award is a solid receipt that the team´s work has been appreciated by our customers" says Axel Schörling, CEO & President at EQL Pharma. For further information, please contact: Phone: +46 (0) 763 – 17 90 60 EQL Pharma AB (publ) in short EQL Pharma AB specializes in developing and selling niche pharmaceuticals. The company currently has more than 20 niche generics (ie generics with limited competition apart from the reference pharmaceutical) approved in the Nordic markets and a couple of originals. In addition to these, there is a significant pipeline of mainly niche generics for launch in 2022 and beyond. The business is currently entirely focused on prescription pharmaceuticals, including hospital products, in the Nordic region and in selected European markets. EQL Pharma AB conducts its operations in Lund and is listed on the Spotlight Stock Market. EQL Pharma AB conducts extensive development work in collaboration with leading contract manufacturers and pharmaceutical companies in the EU and Asia, among others.
Axel Schörling
CEO, EQL Pharma AB (publ)
E-mail: axel.schorling@eqlpharma.com
Website: www.eqlpharma.com
